Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

University of Toronto

$419,013.00

Assessing the Size Dependent Cancer Targeting of Herceptin-coated Nanoparticles

FY 2008-09

Summary
Advances in nanotechnology research have produced a large library of nanoparticles (e.g., quantum dots, metallic nanoparticles, carbon nanotubes, and iron oxide nanoparticles) with distinct optical, electronic, and magnetic properties for many biomedical applications such as a contrast agent and/or drug delivery vehicle for cancer diagnostics and/or therapeutics. These engineered nanoparticles are expected to improve diagnostic sensitivity and accuracy, and enhancing drug delivery and therapy. Multi-functional systems that integrates different nanoparticles and molecules are being developed; these systems are designed for use as agents that can be imaged using two different modes (e.g., magnetic and optical) or can be used as a diagnostic and therapeutic system. These multi-functional systems are expected to make a tremendous impact in the fight against cancer. In order to engineer nanoparticles for in vivo cancer applications, there is a tremendous need to understanding the interactions of the nanoparticle with in vivo biological environment. An elucidation of how the size, shape, and surface chemistry of a nanoparticle interact with the biological environment could lead to development of guidelines that helps in the design of the nanoparticle for biomedical application. This is an immense need for the translation of a nanotechnologies into in vivo biomedical applications.
Program
Operating Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
173003
Name
Chan Warren C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Biomedical Engineering
Projecttitle
Assessing the Size Dependent Cancer Targeting of Herceptin-coated Nanoparticles
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$419,013
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Bio-Distribution; Breast Cancer; Herceptin; Nanotechnology; Targeting
Abstract
Advances in nanotechnology research have produced a large library of nanoparticles (e.g., quantum dots, metallic nanoparticles, carbon nanotubes, and iron oxide nanoparticles) with distinct optical, electronic, and magnetic properties for many biomedical applications such as a contrast agent and/or drug delivery vehicle for cancer diagnostics and/or therapeutics. These engineered nanoparticles are expected to improve diagnostic sensitivity and accuracy, and enhancing drug delivery and therapy. Multi-functional systems that integrates different nanoparticles and molecules are being developed; these systems are designed for use as agents that can be imaged using two different modes (e.g., magnetic and optical) or can be used as a diagnostic and therapeutic system. These multi-functional systems are expected to make a tremendous impact in the fight against cancer. In order to engineer nanoparticles for in vivo cancer applications, there is a tremendous need to understanding the interactions of the nanoparticle with in vivo biological environment. An elucidation of how the size, shape, and surface chemistry of a nanoparticle interact with the biological environment could lead to development of guidelines that helps in the design of the nanoparticle for biomedical application. This is an immense need for the translation of a nanotechnologies into in vivo biomedical applications.
Competitiondate
200809
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Chan, Warren C
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $419,013~ $0~